Hassan Mohammed

ENT SpR

North East Deanery, Newcastle, UK.

Latest Contribution

Allergy journal cover image with Editor's Choice stamp.

Climate change and global health

5 July 2022 | | Rhinology / Sinus | climate change, greenhouse gases, health, pollution

As we put together the Editors’ Choice for Jul/Aug 2022 Journal Reviews, news from a meeting of the G7 energy and environment ministers has been shared that the G7 countries are to stop public funding of any overseas fossil fuel...

Allergy journal cover image.

Eosinophilic or not eosinophilic: dupilumab seems to work

3 May 2022 | | ENT | ENT (rhinitis; biologics; eosinophils; inflammation; nasal polyps), sinusitis

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammation with interleukin (IL)-4, IL-13, and IL-5. Tissue eosinophilia in nasal polyps dramatically increased over a 10-20-year period. Classification of the severity of eosinophil status is expected to lead to...

Allergy journal cover image.

Biologicals for severe chronic rhinosinusitis with nasal polyps. Any use?

5 November 2021 | | Rhinology / Sinus | chronic rhinosinusitis, dupilumab, mepolizumab, omalizumab, reslizumab

Recent advances and knowledge of inflammatory endotypes of chronic rhinosinusitis with nasal polyps (CRSwNP) led to introduction of biological agents such as monoclonal antibodies targeting IgE (omalizumab) and Interleukins (ILs) such as IL4R alpha (dupilumab) and IL5. The European Academy...